Markus P. Vallaster

Medical Head, Hemato-Oncology & Early Oncology Development. Bayes acolyte and adaptive clinical trial design enthusiast. Bring drugs to patients, not patients to drugs.

Role
Medical Head, Hemato-oncology & Early Oncology Development at Astellas Pharma
Location
Boston, MA, US
LinkedIn followers
500 followers

About Markus P. Vallaster

Adaptive clinical trial designs, Bayes acolyte, immune-imaging using novel PET-based technologies.

Experience

  1. Medical Head, Hemato-oncology & Early Oncology Development

    Astellas Pharma

    Apr 2025 — Present

Education

  • UMass Chan Medical School

    Doctor of Philosophy (Ph.D.), Intergenerational Effects of Nicotine in an Animal Model of Paternal Nicotine Exposure

  • Munich School of Philosophy

    Bachelor's Degree, Philosophy

  • Ludwig-Maximilians-Universität München

    Doctor of Biomedical Sciences (Ph.D.), Stem cell therapy in a mouse model of acute cardiac ischaemia

  • Ludwig-Maximilians-Universität München

    Doctor of Medicine (M.D.), Medicine

Find verified contacts for anyone on LinkedIn

Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.

Free plan included · No credit card required

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.

Markus P. Vallaster — Medical Head, Hemato-oncology & Early Oncology Development at Astellas Pharma in Boston, MA, US | Unifers